Advances in Clinical Chemistry, Volume 109, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry, with this new release focusing on Biomarkers of dysfunctional visceral fat, Immunoassay Design and Biotin Interference, Orexin/Hypocretin and Major Psychiatric Disorders and more.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. Biomarkers of dysfunctional visceral fatAlejandro�Gugliucci
2. Biomarkers in Cardiogenic Shock
Johan Lassus
3. Cysteine and related aminothiols in cardiovascular disease, obesity and insulin resistance
Maria Leonor Pavao
4. Oligoclonal bands: an immunological and clinical approach
Carmen Cabrera
5. Immunoassay Design and Biotin Interference
Amitava Dasgupta
6. Orexin/Hypocretin and Major Psychiatric Disorders
Tiao-Lai Huang
Authors
Gregory S. Makowski Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USA.Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.
